N/A
Completed N=152
Complications Associated With Central Venous Access in the NSICU: PICC vs CVC
PICC · Central Venous Catheter · Central Line · Neuro ICU
Source: ClinicalTrials.gov NCT02314520 ↗
Enrolled (actual)
152
Serious AEs
3.3%
Results posted
Jul 2017
Primary outcomePrimary: Participants With Complications With Central Access Including Insertion — 14; 10 Participants — p=0.271
Summary
The goal of this study is to determine whether Peripherally Inserted Central Catheter or Centrally Inserted Venous Catheters have lower complication rates in the Neuroscience Intensive Care Unit. After admission to the Neuroscience ICU and if they require central access, patients will be randomized to receive a PICC or CVC and complications (such as pneumothorax, deep venous thrombosis, infection, etc.) will be tracked and compared between the two interventions.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Participants With Complications With Central Access Including Insertion |
14; 10 | 0.271 |
| SECONDARY Number of Participants With Deep Venous Thrombosis |
4; 0 | — |
| SECONDARY Number of Patients With Complications Related to Insertion |
8; 6 | — |
| SECONDARY Number of Participants With a Central Line Associated Blood Stream Infection |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
Adult patients admitted to the NSICU, who require central access for the treatment of their illness.
Exclusion Criteria
- Current or recent (within 1 month) diagnosis of bacteremia
- Current or recent (within 1 year with confirmed resolution by imaging) deep venous thrombosis
- Existing central access
- Non-English speaking
- Requirement for emergent central access and unable to obtain consent in an emergency setting
Data sourced from ClinicalTrials.gov (NCT02314520). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.